The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Angela Hwang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, University College London Hospital NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Recent treatment advancements in multiple myeloma have led to significant improvements in patient outcomes. Maintenance therapy following autologous haematopoietic stem cell transplantation (AHCT) is now standard of care and has been demonstrated to prolong and deepen treatment responses. Currently, lenalidomide remains the single agent that has been approved for maintenance post‐AHCT in Europe and the USA which, if tolerated, is continued until disease progression. The treatment landscape is rapidly expanding however, and the optimal personalised maintenance approach for a patient is becoming more complex. Treatment outcomes for patients with high‐risk disease remain poor and choice of maintenance in this population also remains unclear. This review article evaluates up‐to‐date literature regarding established maintenance approaches. It further analyses ongoing studies exploring maintenance regimens using combination and novel agents, approaches to maintenance in patients with cytogenetic high‐risk disease and minimal residual disease response‐adapted strategies that reflect the current evolving treatment paradigm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, University College London Hospital NHS Foundation Trust, London, UK.
- Department of Haematology, St James's Hospital, Dublin, Ireland.
- The Institute of Cancer Research, London, UK.
- Département d'Hématologie, Hôpital Pitié Salpêtrière, AP-HP, Paris, France.
ORCID-Profile: Angela Hwang, Patrick Hayden, Charlotte Pawlyn, Donal McLornan, Laurent Garderet
Förderung
- Cancer Research UK
Zitieren
APA
Hwang, A., Hayden, P., Pawlyn, C., McLornan, D., & Garderet, L. (2024). The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology. https://doi.org/10.1111/bjh.19353
Vancouver
Hwang A, Hayden P, Pawlyn C, McLornan D, Garderet L. The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology. 2024. doi:10.1111/bjh.19353
BibTeX
@article{Hwang2024,
author = {Hwang, Angela and Hayden, Patrick and Pawlyn, Charlotte and McLornan, Donal and Garderet, Laurent},
title = {The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19353}
}
EUVIMED